U.S. Markets closed

Ampio Pharmaceuticals, Inc. (AMPE)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.7700-0.0500 (-2.75%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.77
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.9800
52 Week Low 30.4500
50-Day Moving Average 31.7379
200-Day Moving Average 31.3719

Share Statistics

Avg Vol (3 month) 33.71M
Avg Vol (10 day) 31.24M
Shares Outstanding 5195.63M
Implied Shares Outstanding 6N/A
Float 181.49M
% Held by Insiders 17.23%
% Held by Institutions 114.98%
Shares Short (Apr 14, 2021) 419.85M
Short Ratio (Apr 14, 2021) 411.85
Short % of Float (Apr 14, 2021) 410.28%
Short % of Shares Outstanding (Apr 14, 2021) 410.15%
Shares Short (prior month Mar 14, 2021) 419.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Jul 31, 2008

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-53.67%
Return on Equity (ttm)-132.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.66M
Net Income Avi to Common (ttm)-15.89M
Diluted EPS (ttm)-0.0920
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.35M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)1.21M
Total Debt/Equity (mrq)6.90
Current Ratio (mrq)10.08
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-14.73M
Levered Free Cash Flow (ttm)-9.15M